The body's biological response to injury or stress, implicated in dementia risk when chronic.Inflammation is the body's coordinated reaction to damage, infection, or persistent stress. It is not a disease in itself but a process: blood vessels widen and become leaky, immune cells migrate into the affected tissue, and signalling molecules called cytokines orchestrate the cleanup and repair. This response is normally short-lived and protective, resolving once the threat is gone. When it fails to switch off, however, it becomes chronic, and chronic inflammation is now understood as a contributing factor to many long-term conditions, including cardiovascular disease and neurodegenerative disorders such as dementia.
The four cardinal signs of inflammation — redness, heat, swelling, and pain — were described by the Roman encyclopaedist Aulus Cornelius Celsus in the first century AD. The role of cells and soluble mediators was worked out from the nineteenth century onward, beginning with the observations of pathologists such as Rudolf Virchow and Elie Metchnikoff.
Tissue-resident immune cells detect signs of injury or foreign molecules and release chemical alarms. These alarms recruit white blood cells from the bloodstream into the tissue, where they neutralise pathogens and clear debris. The same signals also cause local pain, heat, redness, and swelling. In a healthy resolution phase, anti-inflammatory signals dampen the response and repair cells rebuild the tissue. If the trigger persists or the shut-off signals fail, the process continues at a low level, gradually damaging surrounding cells.
Anti-inflammatory drugs, from aspirin to modern biologics that block specific cytokines, are among the most widely used medicines; measuring inflammatory markers in blood helps assess risk in chronic disease.
The word 'inflammation' comes from the Latin for 'setting on fire', reflecting the heat and redness that Celsus noted two thousand years ago.